CompletedNot applicableNCT03796052
Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients
Studying Ichthyosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johnson & Johnson Consumer Inc. (J&JCI)
- Principal Investigator
- Mario Lacouture, M.D., MDMemorial Sloan Kettering Cancer Center
- Intervention
- Avena Sativa Skincare Regimen(other)
- Enrollment
- 53 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2019 – 2019
Study locations (1)
- Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03796052 on ClinicalTrials.govOther trials for Ichthyosis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONEARLY PHASE1NCT07050810Thera-Clean® Microbubbles System in Patients With Skin DiseasesNorthwestern University
- ENROLLING BY INVITATIONNANCT06330324Reproductive Options in Inherited Skin DiseasesMaastricht University Medical Center
- RECRUITINGNANCT06330350Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive CounsellingMaastricht University Medical Center